Ingenuity Canonical Pathways | -log(p-value) | Ratio | Molecules |
---|---|---|---|
Pyrimidine Ribonucleotides Interconversion | 2.58 | 0.0444 | NME4,SMARCAL1 |
Pyrimidine Ribonucleotides De Novo Biosynthesis | 2.55 | 0.0426 | NME4,SMARCAL1 |
Salvage Pathways of Pyrimidine Ribonucleotides | 1.95 | 0.0211 | NME4,POMK |
Pyrimidine Deoxyribonucleotides De Novo Biosynthesis I | 1.42 | 0.0435 | NME4 |
Nucleotide Excision Repair Pathway | 1.24 | 0.0286 | POLR2B |
Assembly of RNA Polymerase II Complex | 1.09 | 0.02 | POLR2B |
Pyridoxal 5′-phosphate Salvage Pathway | 0.983 | 0.0154 | POMK |
Mitotic Roles of Polo-Like Kinase | 0.977 | 0.0152 | ANAPC5 |
Protein Kinase A Signaling | 0.836 | 0.005 | PTPN14,ANAPC5 |
Androgen Signaling | 0.767 | 0.00901 | POLR2B |
p38 MAPK Signaling | 0.736 | 0.00833 | MKNK1 |
RhoA Signaling | 0.723 | 0.00806 | RAPGEF6 |
Estrogen Receptor Signaling | 0.711 | 0.00781 | POLR2B |
Hereditary Breast Cancer Signaling | 0.665 | 0.00694 | POLR2B |
IL-12 Signaling and Production in Macrophages | 0.66 | 0.00685 | REL |
Regulation of eIF4 and p70S6K Signaling | 0.632 | 0.00637 | MKNK1 |
CREB Signaling in Neurons | 0.568 | 0.00538 | POLR2B |
RAR Activation | 0.56 | 0.00526 | REL |
ERK/MAPK Signaling | 0.541 | 0.005 | MKNK1 |
Systemic Lupus Erythematosus Signaling | 0.499 | 0.00444 | SNRNP200 |
Huntington’s Disease Signaling | 0.461 | 0.004 | POLR2B |
Protein Ubiquitination Pathway | 0.441 | 0.00377 | ANAPC5 |
Glucocorticoid Receptor Signaling | 0.358 | 0.00295 | POLR2B |
Axonal Guidance Signaling | 0.27 | 0.00221 | MKNK1 |